Artemis combines advanced AI, molecular modelling and functional validation to discover and develop proprietary small-molecule therapeutics. Our model is built around owning and advancing high-value drug candidates.

Artemis builds on DeepDocking™, the AI-accelerated virtual screening platform pioneered by co-founder Dr. Artem Cherkasov, enabling structure-based drug discovery at genome-wide scale.